1-3 of 3
Ana Silva-Pinto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase III, multicenter, randomized, placebo controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy, in adolescent and adult sickle cell disease patients with frequent vaso-occlusive crises: The sparkle study

Free
Andrew Campbell, Ana Silva-Pinto, Obiageli Nnodu, Deepa Manwani, Deborah Keefe, Jimmy Watson, Evgeniya Reshetnyak, Velusamy Muthusamy, Partha Banerjee, Olufolake Egbujo (Adisa), Michele Nassin, Yvonne Dei-Adomakoh
Journal: Blood
Blood (2025) 146 (Supplement 1): 1198.
https://doi.org/10.1182/blood-2025-1198
Published: 2025
Journal Articles

Hematopoietic stem cell transplantation with reduced toxicity myeloablative conditioning regimen for children and adults with sickle cell disease: A brazilian single center experience.

Free
Thalita Costa, Luiz Darrigo-Junior, Fabiano Pieroni, Carlos Eduardo Grecco, Ana Beatriz Stracieri, Juliana Dias, Joana Faria, Pedro Valeri, Lucas Cota, Gabriela De Almeida, Camila Donadel, Renata Guimarães, Ana Silva-Pinto, Maria Carolina Oliveira, Gil De Santis, Belinda Simões, Fabiola Traina
Journal: Blood
Blood (2025) 146 (Supplement 1): 4221.
https://doi.org/10.1182/blood-2025-4221
Published: 2025
Journal Articles

Sickle cell disease trials redefined: Toward unified clinical endpoints through international consensus

Free
Mohamed Yassin, Nirmish Shah, Andrew Campbell, Salam Al-Kindi, Wally Smith, Charles Jonassaint, Miguel Abboud, Raffaella Colombatti, Dipty Jain, Halima Bello-Manga, Mariane de Montalembert, Ana Silva-Pinto, Steven Okoli, Abdelaziz Fahem, Biree Andemariam
Journal: Blood
Blood (2025) 146 (Supplement 1): 1166.
https://doi.org/10.1182/blood-2025-1166
Published: 2025